Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Impact of the COVID-19 Pandemic on Mental Health, Physical Activity and Sleep in Children with Neuroinflammatory Disorders
Child Neurology and Developmental Neurology
Child Neurology and Developmental Neurology Posters (7:00 AM-5:00 PM)
054

To assess changes in anxiety, fatigue, depression, physical activity, and sleep associated with the COVID-19 pandemic in youth with neuroinflammatory disorders.

Children with neuroinflammatory disorders have high rates of anxiety, depression, and fatigue, plus reduced physical activity compared to healthy counterparts. We examined whether patients with neuroinflammatory disorders would show changes in the above domains associated with COVID-19, hypothesizing poorer outcomes in patients with chronic/recurrent disease.

Children with neuroinflammatory disorders completed questionnaires from March-August 2020 (n=129): Screen for Childhood Anxiety and Related Disorders, Centre for Epidemiologic Studies Depression scale for Children, Pediatric Quality of Life Multidimensional Fatigue Scale, Godin Leisure-Time Exercise Questionnaire, and Children’s Sleep Habits Questionnaire. Clinical/demographic data were collected via standardized Case Report Form. We used pre-pandemic data for paired analysis where available (n=87).

Participants were 57% female (mean age: 13±4 years). Children with monophasic Acquired Demyelinating Syndrome (monoADS) engaged in moderate/vigorous physical activity a mean of 6±4 times/week pre-pandemic (n=61), and 5±4 during the pandemic (n=62). Children with chronic/recurrent neuroinflammation (crNI; Multiple Sclerosis (MS) and neuroinflammation with systemic involvement) exercised 4±3 times/week pre-pandemic (n=21 (14 MS)), and 4±2 during (n=25 (15 MS)) (monoADS vs crNI: p=0.076). Across all groups, the pandemic brought a rise in sleep time (9±1 versus 10±2 hours, p<0.001), and improved sleep-rest fatigue (p=0.05). Despite this, children with MS reported more sleep-rest fatigue compared to monoADS (p=0.043). Average rates of depression and anxiety were similar pre/post-pandemic (29%/31%, p=0.507; 16%/17%, p=0.857). During the pandemic, however, rates of depression/anxiety were significantly different by disease type: systemic involvement (60%/50%), MS (33%/27%), monoADS (22%/16%)(Chi-square, p=0.048/0.049).

With the pandemic, despite increased sleep, youth with neuroinflammatory disorders continued to display high rates of depression/anxiety and reduced physical activity. There were significantly different rates of depression/anxiety between disease types. Individuals with recurrent disease had more fatigue than those with monophasic disease.

Authors/Disclosures
Lindsey Vogt, MD (Work)
PRESENTER
Dr. Vogt has nothing to disclose.
Beyza Ciftci Kavaklioglu, MD (University of Wester Ontario, London Health Sciences Centre) Dr. Ciftci Kavaklioglu has nothing to disclose.
Giulia Longoni, MD (The Hospital for Sick Children) Dr. Longoni has nothing to disclose.
No disclosure on file
No disclosure on file
No disclosure on file
E. Ann Yeh, MD, MA, FRCPC (Hospital for Sick Children) Dr. Yeh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline therapeutics. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SCN. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Yeh has received research support from CIHR. The institution of Dr. Yeh has received research support from National MS Society. The institution of Dr. Yeh has received research support from SickKids Foundation. The institution of Dr. Yeh has received research support from MSSC. The institution of Dr. Yeh has received research support from Garry Hurvitz Foundation. The institution of Dr. Yeh has received research support from Leong Centre. The institution of Dr. Yeh has received research support from OMSLife. The institution of Dr. Yeh has received research support from Canada's Drug Agency. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as a Author with Medscape. Dr. Yeh has a non-compensated relationship as a Editorial Board with Neurology that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Yeh has a non-compensated relationship as a Editorial Board with MSJ that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.